Patents by Inventor Fengting Yan

Fengting Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9676749
    Abstract: Disclosed herein are compositions and methods for cancer detection and treatment. Compounds that inhibit PRMT5 are contemplated, as are pharmaceutical compositions comprising a therapeutically effective amount of at least one PRMT5 inhibitor. In some embodiments pharmaceutical compositions further comprising at least one HDAC inhibitor are contemplated. Methods of treating disorders in a mammal by inhibiting PRMT5 by administering to a mammal, a therapeutically effective amount of a PRMT5 inhibitor are also disclosed.
    Type: Grant
    Filed: May 4, 2015
    Date of Patent: June 13, 2017
    Assignee: Ohio State Innovation Foundation
    Inventors: Robert Baiocchi, Chenglong Li, Pui Kai Li, Fengting Yan
  • Publication number: 20160052910
    Abstract: Disclosed herein are compositions and methods for cancer detection and treatment. Compounds that inhibit PRMT5 are contemplated, as are pharmaceutical compositions comprising a therapeutically effective amount of at least one PRMT5 inhibitor. In some embodiments pharmaceutical compositions further comprising at least one HDAC inhibitor are contemplated. Methods of treating disorders in a mammal by inhibiting PRMT5 by administering to a mammal, a therapeutically effective amount of a PRMT5 inhibitor are also disclosed.
    Type: Application
    Filed: May 4, 2015
    Publication date: February 25, 2016
    Applicant: Ohio State Innovation Foundation
    Inventors: Robert Baiocchi, Chenglong Li, Pui Kai Li, Fengting Yan
  • Patent number: 9044432
    Abstract: Disclosed herein are compositions and methods for cancer detection and treatment. Compounds that inhibit PRMT5 are contemplated, as are pharmaceutical compositions comprising a therapeutically effective amount of at least one PRMT5 inhibitor. In some embodiments pharmaceutical compositions further comprising at least one HDAC inhibitor are contemplated. Methods of treating disorders in a mammal by inhibiting PRMT5 by administering to a mammal, a therapeutically effective amount of a PRMT5 inhibitor are also disclosed.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: June 2, 2015
    Assignee: Ohio State Innovation Foundation
    Inventors: Robert Baiocchi, Chenglong Li, Pui Kai Li, Fengting Yan
  • Publication number: 20130059892
    Abstract: Disclosed herein are compositions and methods for cancer detection and treatment. Compounds that inhibit PRMT5 are contemplated, as are pharmaceutical compositions comprising a therapeutically effective amount of at least one PRMT5 inhibitor. In some embodiments pharmaceutical compositions further comprising at least one HDAC inhibitor are contemplated. Methods of treating disorders in a mammal by inhibiting PRMT5 by administering to a mammal, a therapeutically effective amount of a PRMT5 inhibitor are also disclosed.
    Type: Application
    Filed: December 22, 2010
    Publication date: March 7, 2013
    Applicant: The Ohio State University Research Foundation
    Inventors: Robert Baiocchi, Chenglong Li, Pui Kai Li, Fengting Yan
  • Patent number: D981575
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: March 21, 2023
    Assignee: SHENZHEN JIEQU TECHNOLOGY CO., LTD.
    Inventor: FengTing Yan